The Safety and Long-Term Clinical Benefit of PCSK9i in STEMI Patients
Clinical trial NCT05579418 · UNKNOWN
Trial details
- NCT number
- NCT05579418
- Sponsor
- Hamad Medical Corporation
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2024-10-30
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.